Loading insider details...
Beta
Latest Form 4 (Jun 5, 2026): Grant/Award of 6,408 DNLI shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 5, 2026 | Denali Therapeutics Inc. (DNLI) | Grant/Award | 6,408 | n/a |
| Jun 5, 2025 | Denali Therapeutics Inc. (DNLI) | Grant/Award | 6,037 | n/a |
| Mar 14, 2025 | F5, INC. (FFIV) | Exercise/Conversion | 1,309 | n/a |
| Sep 6, 2024 | F5, INC. (FFIV) | Gift | 1,000 | n/a |
| Aug 8, 2024 | Accolade, Inc. (ACCD) | Exercise/Conversion | 9,196 | n/a |
| Aug 8, 2024 | Accolade, Inc. (ACCD) | Grant/Award | 35,021 | n/a |
| Jun 4, 2024 | Denali Therapeutics Inc. (DNLI) | Grant/Award | 5,967 | n/a |
| Mar 15, 2024 | F5, INC. (FFIV) | Exercise/Conversion | 1,770 | n/a |
| Sep 7, 2023 | F5, INC. (FFIV) | Gift | 1,200 | n/a |
| Jun 16, 2023 | Sarcos Technology & Robotics Corp (STRC) | Grant/Award | 195,059 | n/a |